What does therapeutic development — sales & marketing mean?

This includes all costs related to the promotion, advertising, and sales efforts for products or services within the therapeutic development segment. It provides insight into the company's investment in market penetration and customer acquisition for its therapeutic offerings.

Fulgent Genetics, Inc. FLGT Therapeutic Development — Sales & Marketing

Other segment segments

Laboratory Services

$11.58M+52.8%

Similar metrics at other companies

CRMDOther selling and marketing — Total selling and marketing expense

$5.23M+117%

DBVTExpenses by function — Sales & Marketing

$1M+400%

GKOSDevelopment And Commercialization Of Ophthalmic Therapies — Sales & Marketing

$46.29M+34.4%

TRNSDistribution — Sales & Marketing

$3.74M+6.9%

CRMDEmployee Expense — Sales & Marketing

$5.65M+67.6%

ADMAADMA Bio Manufacturing — Sales & Marketing

$7.2M+19.1%

Other financials

Income statement

See full

Revenue$71.1M-3.2%

Gross profit$21.5M-24.2%

Operating income-$34.6M-74.9%

Net income-$24.8M-115%

EPS (diluted)-$0.80-116%

Balance sheet

See full

Cash & equivalents$23.4M-65.2%

Total debt$8.2M+40.5%

Total equity$1.0B-6.9%

Total assets$1.2B-4.1%

Cash flow

See full

Operating cash flow$7.1M+260%

CapEx$5.2M+10.3%

Free cash flow$1.9M+121%

Valuation

See full

Market cap$552.11M-7.1%

Enterprise value$536.92M+0.7%

P/S1.7×-0.3×

Profitability

See full

Gross margin38.7%-0.1pp

Operating margin-33.1%+17.4pp

Net margin-23%+43.3pp

FCF margin-36.9%—

Returns & leverage

See full

Return on equity-6.8%+48.2pp

Debt / equity0×0.0×

Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s therapeutic development — sales & marketing.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s therapeutic development — sales & marketing?: Fulgent Genetics, Inc. (FLGT) reported therapeutic development — sales & marketing of $0 in Q1 2026.
What does therapeutic development — sales & marketing mean?: This includes all costs related to the promotion, advertising, and sales efforts for products or services within the therapeutic development segment. It provides insight into the company's investment in market penetration and customer acquisition for its therapeutic offerings.